News

Half of Atrial Fibrillation Patients Discontinue Warfarin
Rachel Lutz
More than half of atrial fibrillation patients discontinue or interrupt warfarin therapy within 1 year of starting treatment.
Krystle Vermes
Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.
Meghan Ross, Associate Editor
An independent pharmacy will pay a $46,000 settlement over an alleged lack of break times for its employees.
Allison Gilchrist, Associate Editor
Pharmacists must prepare for full enforcement of the Drug Supply Chain Security Act (DSCSA) in order to avoid significant penalties associated with noncompliance.
Davy James, Managing Editor of Specialty Pharmacy Times, and Meghan Ross, Associate Editor
The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.
Allison Gilchrist, Associate Editor
Drug manufacturers spent $3.4 billion on advertising the top 10 brand-name prescription drugs last year.
Krystle Vermes
Pharmacies are now stocking Mylan’s generic version of Pfizer’s Zosyn injection.
Meghan Ross, Associate Editor
A new type 2 diabetes (T2D) treatment for adult patients, empagliflozin and metformin (Synjardy), was approved by the FDA today.

Association News

The National Association of Chain Drug Stores today announced the winners of the 2015 NACDS Total Store Expo Product Showcase.
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued a statement in response to the J.D. Power 2015 U.S. Pharmacy StudySM released today.
NACDS today bestowed pharmacy’s highest honor – the Harold W. Pratt Award – to industry leader Robert Thompson during today’s business program at the 2015 NACDS Total Store Expo.
In conjunction with IMS Health, the NACDS Foundation recognized two industry leaders with the IMS Health Bernie Greenberg Pharmacy Partnership Award.

Pharmacy Market News

Valeant Pharmaceuticals has announced that it has entered into a definitive agreement under which it will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical
Celgene Corporation today announced it has closed its acquisition of Receptos, Inc.
Novo Nordisk today announced that it has entered into a definitive agreement under which Novo Nordisk will acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Indiana, US.

Strategic Alliance Partner News

CVS Health has entered into new clinical affiliations with St. Luke’s University Health Network in Bethlehem, Pennsylvania, and TriHealth in Cincinnati, Ohio.
Walgreens and Providence Health & Services have announced a strategic clinical collaboration aimed at coordinating patient care and improving patient access, which plans to bring up to 25 new retail clinics to Oregon and Washington.
$AD300x250BB$
Latest Issues
$auto_registration$